TP53 and breast carcinoma: Normal mammary cells associated with tumors in breast cancer patients may also harbor pathogenic variants of p53 and PIK3CA (102), suggesting that clonal (and genetic/molecular) heterogeneity may be a fundamental feature of mammary cells.